Poseida Therapeutics Statistics
Total Valuation
PSTX has a market cap or net worth of $199.73 million. The enterprise value is $72.95 million.
| Market Cap | 199.73M |
| Enterprise Value | 72.95M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PSTX has 96.49 million shares outstanding. The number of shares has increased by 25.34% in one year.
| Shares Outstanding | 96.49M |
| Shares Change (YoY) | +25.34% |
| Shares Change (QoQ) | +4.22% |
| Owned by Insiders (%) | 34.52% |
| Owned by Institutions (%) | 47.64% |
| Float | 54.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.09 |
| Forward PS | 4.20 |
| PB Ratio | 1.93 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.18, with a Debt / Equity ratio of 0.82.
| Current Ratio | 3.18 |
| Quick Ratio | 3.10 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.22 |
Financial Efficiency
Return on equity (ROE) is -94.90% and return on invested capital (ROIC) is -68.48%.
| Return on Equity (ROE) | -94.90% |
| Return on Assets (ROA) | -42.20% |
| Return on Capital (ROIC) | -68.48% |
| Revenue Per Employee | $196,070 |
| Profits Per Employee | -$374,030 |
| Employee Count | 330 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PSTX has paid $107,000 in taxes.
| Income Tax | 107,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.00% in the last 52 weeks. The beta is 0.36, so PSTX's price volatility has been lower than the market average.
| Beta (1Y) | 0.36 |
| 52-Week Price Change | -25.00% |
| 50-Day Moving Average | 3.11 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 32.77 |
| Average Volume (30 Days) | 740,443 |
Short Selling Information
The latest short interest is 4.12 million, so 4.27% of the outstanding shares have been sold short.
| Short Interest | 4.12M |
| Short Previous Month | 3.84M |
| Short % of Shares Out | 4.27% |
| Short % of Float | 7.55% |
| Short Ratio (days to cover) | 4.46 |
Income Statement
In the last 12 months, PSTX had revenue of $64.70 million and -$123.43 million in losses. Loss per share was -$1.37.
| Revenue | 64.70M |
| Gross Profit | 64.70M |
| Operating Income | -129.50M |
| Pretax Income | -123.32M |
| Net Income | -123.43M |
| EBITDA | -109.04M |
| EBIT | -114.65M |
| Loss Per Share | -$1.37 |
Balance Sheet
The company has $212.20 million in cash and $85.42 million in debt, giving a net cash position of $126.78 million or $1.31 per share.
| Cash & Cash Equivalents | 212.20M |
| Total Debt | 85.42M |
| Net Cash | 126.78M |
| Net Cash Per Share | $1.31 |
| Equity / Book Value | 103.70M |
| Book Value Per Share | 1.07 |
| Working Capital | 155.16M |
Cash Flow
In the last 12 months, operating cash flow was -$92.17 million and capital expenditures -$3.07 million, giving a free cash flow of -$95.23 million.
| Operating Cash Flow | -92.17M |
| Capital Expenditures | -3.07M |
| Free Cash Flow | -95.23M |
| FCF Per Share | -$1.06 |
Margins
Gross margin is 100.00%, with operating and profit margins of -200.15% and -190.76%.
| Gross Margin | 100.00% |
| Operating Margin | -200.15% |
| Pretax Margin | -190.60% |
| Profit Margin | -190.76% |
| EBITDA Margin | -168.52% |
| EBIT Margin | -177.20% |
| FCF Margin | -147.18% |
Dividends & Yields
PSTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.34% |
| Shareholder Yield | -25.34% |
| Earnings Yield | -61.80% |
| FCF Yield | -47.68% |
Analyst Forecast
The average price target for PSTX is $14.67, which is 608.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.67 |
| Price Target Difference | 608.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 23.86% |
| EPS Growth Forecast (5Y) | -29.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PSTX has an Altman Z-Score of -2.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.8 |
| Piotroski F-Score | 2 |